Chemours Stock Plunges 11.4% on Earnings Miss, Dividend Cut

The Chemours Company's stock experienced a significant drop of 11.4% in pre-market trading on May 7, 2025, driven by a series of unfavorable developments.

The specialty chemicals firm reported a net loss of $4 million, or $0.03 per share, for the first quarter of 2025, a stark contrast to the profit of $54 million, or $0.36 per share, reported in the same period last year. This financial setback was compounded by a 65% reduction in the quarterly dividend to $0.0875 per share, aimed at bolstering the company's financial stability.

Additionally, the company missed its earnings estimates for the first quarter, posting adjusted earnings per share of $0.13, which fell short of the consensus estimate of $0.23. Despite revenue coming in slightly ahead at $1.37 billion, the overall financial performance failed to meet market expectations, contributing to the stock's decline.

Analysts from Truist Financial also revised their target price for Chemours shares, lowering it from $27.00 to $22.00 while maintaining a "buy" rating. This adjustment reflects the market's cautious outlook on the company's near-term prospects.